Pasireotide is primarily used in the treatment of conditions related to hormonal imbalances. It is particularly effective in managing Cushing's disease, a disorder caused by excessive production of cortisol. By inhibiting the release of hormones that stimulate cortisol production, it helps alleviate symptoms such as weight gain, high blood pressure, and glucose intolerance. Additionally, it is utilized in the treatment of acromegaly, a condition characterized by excessive growth hormone secretion. Pasireotide helps control the symptoms by reducing growth hormone levels, improving patient outcomes. Its application in these endocrine disorders underscores its role in regulating hormone-related abnormalities.